Suppr超能文献

社会经济因素对在依赖血管活性药物之前患者对早期左心室辅助装置治疗的意愿的影响。

Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence.

作者信息

Tchoukina Inna, Shah Keyur B, Thibodeau Jennifer T, Estep Jerry D, Lala Anuradha, Lanfear David E, Gilotra Nisha A, Pamboukian Salpy V, Horstmanshof Douglas A, Mcnamara Dennis M, Haas Donald C, Jorde Ulrich P, Mclean Rhondalyn C, Cascino Thomas M, Khalatbari Shokoufeh, Richards Blair, Yosef Matheos, Spino Cathie, Baldwin J Timothy, Mann Douglas L, Aaronson Keith D, Stewart Garrick C

机构信息

Virginia Commonwealth University, Richmond, Virginia.

Virginia Commonwealth University, Richmond, Virginia.

出版信息

J Card Fail. 2020 Apr;26(4):316-323. doi: 10.1016/j.cardfail.2019.11.026. Epub 2019 Dec 4.

Abstract

BACKGROUND

Worsening heart failure (HF) and health-related quality of life (HRQOL) have been shown to impact the decision to proceed with left ventricular assist device (LVAD) implantation, but little is known about how socioeconomic factors influence expressed patient preference for LVAD.

METHODS AND RESULTS

Ambulatory patients with advanced systolic HF (n=353) reviewed written information about LVAD therapy and completed a brief survey to indicate whether they would want an LVAD to treat their current level of HF. Ordinal logistic regression analyses identified clinical and demographic predictors of LVAD preference. Higher New York Heart Association (NYHA) class, worse HRQOL measured by Kansas City Cardiomyopathy Questionnaire, lower education level, and lower income were significant univariable predictors of patients wanting an LVAD. In the multivariable model, higher NYHA class (OR [odds ratio]: 1.43, CI [confidence interval]: 1.08-1.90, P = .013) and lower income level (OR: 2.10, CI: 1.18 - 3.76, P = .012 for <$40,000 vs >$80,000) remained significantly associated with wanting an LVAD.

CONCLUSION

Among ambulatory patients with advanced systolic HF, treatment preference for LVAD was influenced by level of income independent of HF severity. Understanding the impact of socioeconomic factors on willingness to consider LVAD therapy may help tailor counseling towards individual needs.

摘要

背景

心力衰竭(HF)病情恶化及健康相关生活质量(HRQOL)已被证明会影响左心室辅助装置(LVAD)植入决策,但对于社会经济因素如何影响患者对LVAD的明确偏好知之甚少。

方法与结果

晚期收缩性HF门诊患者(n = 353)阅读了关于LVAD治疗的书面信息,并完成了一项简短调查,以表明他们是否希望使用LVAD来治疗其当前的HF水平。有序逻辑回归分析确定了LVAD偏好的临床和人口统计学预测因素。较高的纽约心脏协会(NYHA)分级、堪萨斯城心肌病问卷测量的较差HRQOL、较低的教育水平和较低的收入是患者希望使用LVAD的显著单变量预测因素。在多变量模型中,较高的NYHA分级(比值比[OR]:1.43,置信区间[CI]:1.08 - 1.90,P = 0.013)和较低的收入水平(对于<$40,000与>$80,000,OR:2.10,CI:1.18 - 3.76,P = 0.012)仍然与希望使用LVAD显著相关。

结论

在晚期收缩性HF门诊患者中,对LVAD的治疗偏好受收入水平影响,而与HF严重程度无关。了解社会经济因素对考虑LVAD治疗意愿的影响可能有助于根据个体需求调整咨询。

相似文献

1
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence.
J Card Fail. 2020 Apr;26(4):316-323. doi: 10.1016/j.cardfail.2019.11.026. Epub 2019 Dec 4.
6
Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
J Heart Lung Transplant. 2019 Apr;38(4):408-417. doi: 10.1016/j.healun.2018.09.021. Epub 2018 Oct 1.
8
Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS.
J Am Heart Assoc. 2021 Jul 20;10(14):e021196. doi: 10.1161/JAHA.121.021196. Epub 2021 Jul 9.
9
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL.
J Am Heart Assoc. 2021 Jul 20;10(14):e019901. doi: 10.1161/JAHA.120.019901. Epub 2021 Jul 10.
10
Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
J Heart Lung Transplant. 2017 Nov;36(11):1243-1249. doi: 10.1016/j.healun.2017.05.023. Epub 2017 May 20.

引用本文的文献

1
Sex-based Differences in the Utility and Outcomes of Left Ventricular Assist Devices.
J Saudi Heart Assoc. 2025 Feb 5;37(1):6. doi: 10.37616/2212-5043.1418. eCollection 2025.
2
Sex-based considerations for implementation of ventricular assist device therapy.
Front Cardiovasc Med. 2022 Oct 18;9:1011192. doi: 10.3389/fcvm.2022.1011192. eCollection 2022.
5
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL.
J Am Heart Assoc. 2021 Jul 20;10(14):e019901. doi: 10.1161/JAHA.120.019901. Epub 2021 Jul 10.
6
Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006284. doi: 10.1161/CIRCOUTCOMES.119.006284. Epub 2020 May 12.

本文引用的文献

1
A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial).
J Card Fail. 2018 Oct;24(10):661-671. doi: 10.1016/j.cardfail.2018.08.008. Epub 2018 Sep 7.
3
Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.
J Heart Lung Transplant. 2017 Oct;36(10):1080-1086. doi: 10.1016/j.healun.2017.07.005. Epub 2017 Jul 15.
4
Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure.
JACC Heart Fail. 2017 Sep;5(9):663-671. doi: 10.1016/j.jchf.2017.04.009. Epub 2017 Aug 16.
9
Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot.
J Heart Lung Transplant. 2015 Dec;34(12):1630-3. doi: 10.1016/j.healun.2015.07.009. Epub 2015 Aug 4.
10
Reasons Why Eligible Candidates Decline Left Ventricular Assist Device Placement.
J Card Fail. 2015 Oct;21(10):835-9. doi: 10.1016/j.cardfail.2015.06.008. Epub 2015 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验